501 related articles for article (PubMed ID: 7507230)
21. Characterization and functional analysis of the p42Ets-1 variant of the mouse Ets-1 transcription factor.
Lionneton F; Lelièvre E; Baillat D; Stehelin D; Soncin F
Oncogene; 2003 Dec; 22(57):9156-64. PubMed ID: 14668797
[TBL] [Abstract][Full Text] [Related]
22. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
[TBL] [Abstract][Full Text] [Related]
23. Role of ETS1 in IL-2 gene expression.
Romano-Spica V; Georgiou P; Suzuki H; Papas TS; Bhat NK
J Immunol; 1995 Mar; 154(6):2724-32. PubMed ID: 7876544
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation in megakaryocytes: the thrombopoietin receptor gene as a model.
Mignotte V; Deveaux S; Filipe A
Stem Cells; 1996; 14 Suppl 1():232-9. PubMed ID: 11012226
[TBL] [Abstract][Full Text] [Related]
25. The ERGB/Fli-1 gene: isolation and characterization of a new member of the family of human ETS transcription factors.
Watson DK; Smyth FE; Thompson DM; Cheng JQ; Testa JR; Papas TS; Seth A
Cell Growth Differ; 1992 Oct; 3(10):705-13. PubMed ID: 1445800
[TBL] [Abstract][Full Text] [Related]
26. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
[TBL] [Abstract][Full Text] [Related]
27. The c-ets-1 proto-oncogene has oncogenic activity and is positively autoregulated.
Seth A; Papas TS
Oncogene; 1990 Dec; 5(12):1761-7. PubMed ID: 2284095
[TBL] [Abstract][Full Text] [Related]
28. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation.
Wasylyk B; Wasylyk C; Flores P; Begue A; Leprince D; Stehelin D
Nature; 1990 Jul; 346(6280):191-3. PubMed ID: 2114554
[TBL] [Abstract][Full Text] [Related]
29. Identification of an enhancer of the human activating protein-2alpha gene that contains a critical Ets1 binding site.
Cheng YH; Handwerger S
J Clin Endocrinol Metab; 2003 Jul; 88(7):3305-11. PubMed ID: 12843180
[TBL] [Abstract][Full Text] [Related]
30. One of two Ets-binding sites in the cytokeratin EndoA enhancer is essential for enhancer activity and binds to Ets-2 related proteins.
Fujimura Y; Yamamoto H; Hamazato F; Nozaki M
Nucleic Acids Res; 1994 Feb; 22(4):613-8. PubMed ID: 7510396
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the human leukemia inhibitory factor gene by ETS transcription factors.
Bamberger AM; Jenatschke S; Schulte HM; Ellebrecht I; Beil FU; Bamberger CM
Neuroimmunomodulation; 2004; 11(1):10-9. PubMed ID: 14557674
[TBL] [Abstract][Full Text] [Related]
32. Molecular analysis of the ets genes and their products.
Watson DK; Ascione R; Papas TS
Crit Rev Oncog; 1990; 1(4):409-36. PubMed ID: 1964597
[TBL] [Abstract][Full Text] [Related]
33. The human ETS1 gene: genomic structure, promoter characterization and alternative splicing.
Jorcyk CL; Watson DK; Mavrothalassitis GJ; Papas TS
Oncogene; 1991 Apr; 6(4):523-32. PubMed ID: 2030910
[TBL] [Abstract][Full Text] [Related]
34. Identification of a Ets1 variant protein unaffected in its chromatin and in vitro DNA binding capacities by T cell antigen receptor triggering and intracellular calcium rises.
Pognonec P; Boulukos KE; Bosselut R; Boyer C; Schmitt-Verhulst AM; Ghysdael J
Oncogene; 1990 Apr; 5(4):603-10. PubMed ID: 2183162
[TBL] [Abstract][Full Text] [Related]
35. High-affinity DNA-protein interactions of the cellular ETS1 protein: the determination of the ETS binding motif.
Fisher RJ; Mavrothalassitis G; Kondoh A; Papas TS
Oncogene; 1991 Dec; 6(12):2249-54. PubMed ID: 1766672
[TBL] [Abstract][Full Text] [Related]
36. ETS1 transactivates the human GM-CSF promoter in Jurkat T cells stimulated with PMA and ionomycin.
Thomas RS; Tymms MJ; Seth A; Shannon MF; Kola I
Oncogene; 1995 Nov; 11(10):2135-43. PubMed ID: 7478534
[TBL] [Abstract][Full Text] [Related]
37. Regulation of human T cell receptor beta gene expression by Ets-1.
Wotton D; Prosser HM; Owen MJ
Leukemia; 1993 Aug; 7 Suppl 2():S55-60. PubMed ID: 8361234
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic conversion alters the transcriptional properties of ets.
Wasylyk C; Wasylyk B
Cell Growth Differ; 1992 Sep; 3(9):617-25. PubMed ID: 1329927
[TBL] [Abstract][Full Text] [Related]
39. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity.
Nerlov C; Rørth P; Blasi F; Johnsen M
Oncogene; 1991 Sep; 6(9):1583-92. PubMed ID: 1923525
[TBL] [Abstract][Full Text] [Related]
40. [Regulation of T cell antigen receptor alpha chain gene expression].
Kantake M
Arerugi; 1992 Apr; 41(4):532-42. PubMed ID: 1535773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
